• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于基因工程动物定制的CRISPR-Cas9技术

CRISPR-Cas9 in the Tailoring of Genetically Engineered Animals.

作者信息

Urban Wiktoria, Kropacz Marta, Łach Maksymilian, Jankowska Anna

机构信息

Department of Cell Biology, Poznan University of Medical Sciences, 61-701 Poznań, Poland.

出版信息

Curr Issues Mol Biol. 2025 May 4;47(5):330. doi: 10.3390/cimb47050330.

DOI:10.3390/cimb47050330
PMID:40699729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12109904/
Abstract

CRISPR-Cas9 enables targeted genome editing and has become a pivotal tool in biomedical research and animal genome engineering. This review highlights its application in generating genetically modified animals used as preclinical disease models, bioreactors for recombinant protein production, and potential sources of xenotransplantation organs. We also discuss its role in improving livestock traits, welfare, and breeding efficiency. The benefits and limitations of CRISPR-Cas9 are examined, emphasizing its transformative potential in research and agricultural biotechnology.

摘要

CRISPR-Cas9技术可实现靶向基因组编辑,已成为生物医学研究和动物基因组工程中的关键工具。本综述重点介绍了其在生成用作临床前疾病模型的转基因动物、用于重组蛋白生产的生物反应器以及异种移植器官潜在来源方面的应用。我们还讨论了其在改善家畜性状、福利和繁殖效率方面的作用。本文审视了CRISPR-Cas9的优势与局限性,强调了其在研究和农业生物技术中的变革潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ba/12109904/c7272dc52a15/cimb-47-00330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ba/12109904/0e76d2be4542/cimb-47-00330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ba/12109904/c7272dc52a15/cimb-47-00330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ba/12109904/0e76d2be4542/cimb-47-00330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ba/12109904/c7272dc52a15/cimb-47-00330-g002.jpg

相似文献

1
CRISPR-Cas9 in the Tailoring of Genetically Engineered Animals.用于基因工程动物定制的CRISPR-Cas9技术
Curr Issues Mol Biol. 2025 May 4;47(5):330. doi: 10.3390/cimb47050330.
2
Advancing crop disease resistance through genome editing: a promising approach for enhancing agricultural production.通过基因组编辑提升作物抗病性:一种提高农业产量的有前景的方法。
Front Genome Ed. 2024 Jun 26;6:1399051. doi: 10.3389/fgeed.2024.1399051. eCollection 2024.
3
A review on molecular scissoring with CRISPR/Cas9 genome editing technology.关于利用CRISPR/Cas9基因组编辑技术进行分子剪接的综述。
Toxicol Res (Camb). 2024 Jul 12;13(4):tfae105. doi: 10.1093/toxres/tfae105. eCollection 2024 Aug.
4
CRISPR/Cas9-mediated genome editing in Ganoderma lucidum: recent advances and biotechnological opportunities.CRISPR/Cas9介导的灵芝基因组编辑:最新进展与生物技术机遇
World J Microbiol Biotechnol. 2025 Jun 25;41(7):223. doi: 10.1007/s11274-025-04458-9.
5
Transferable approaches to CRISPR-Cas9 induced genome editing in non-model insects: a brief guide.非模式昆虫中CRISPR-Cas9介导的基因组编辑的可转移方法:简要指南
Front Zool. 2025 Jul 7;22(1):13. doi: 10.1186/s12983-025-00566-2.
6
Off-target interactions in the CRISPR-Cas9 Machinery: mechanisms and outcomes.CRISPR-Cas9机制中的脱靶相互作用:机制与结果
Biochem Biophys Rep. 2025 Jul 5;43:102134. doi: 10.1016/j.bbrep.2025.102134. eCollection 2025 Sep.
7
CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment.CRISPR-Cas9在心血管医学中的应用:开启治疗新潜力
Cells. 2025 Jan 17;14(2):131. doi: 10.3390/cells14020131.
8
CRISPR/Cas genome editing in soybean: challenges and new insights to overcome existing bottlenecks.大豆中的CRISPR/Cas基因组编辑:克服现有瓶颈的挑战与新见解
J Adv Res. 2024 Aug 18. doi: 10.1016/j.jare.2024.08.024.
9
Unlocking the potential of CRISPR-Cas9 for cystic fibrosis: A systematic literature review.挖掘CRISPR-Cas9治疗囊性纤维化的潜力:一项系统文献综述
Gene. 2025 Mar 20;942:149257. doi: 10.1016/j.gene.2025.149257. Epub 2025 Jan 18.
10
Application of CRISPR-Cas9 in microbial cell factories.CRISPR-Cas9在微生物细胞工厂中的应用。
Biotechnol Lett. 2025 Apr 21;47(3):46. doi: 10.1007/s10529-025-03592-6.

引用本文的文献

1
Candidate Genes, Markers, Signatures of Selection, and Quantitative Trait Loci (QTLs) and Their Association with Economic Traits in Livestock: Genomic Insights and Selection.候选基因、标记、选择特征、数量性状位点(QTLs)及其与家畜经济性状的关联:基因组见解与选择
Int J Mol Sci. 2025 Aug 8;26(16):7688. doi: 10.3390/ijms26167688.

本文引用的文献

1
Contributions of Europeans to Xenotransplantation Research: 1. Pig Organ Xenotransplantation.欧洲人对异种移植研究的贡献:1. 猪器官异种移植
Transpl Int. 2025 Feb 27;38:14041. doi: 10.3389/ti.2025.14041. eCollection 2025.
2
Comprehensive transcriptomic analysis of myostatin-knockout pigs: insights into muscle growth and lipid metabolism.肌肉生长抑制素基因敲除猪的综合转录组分析:对肌肉生长和脂质代谢的见解
Transgenic Res. 2025 Feb 20;34(1):12. doi: 10.1007/s11248-025-00431-2.
3
gene editing using primary cells derived from Cas9-expressing pigs.
使用源自表达Cas9的猪的原代细胞进行基因编辑。
J Anim Sci Technol. 2025 Jan;67(1):179-192. doi: 10.5187/jast.2024.e77. Epub 2025 Jan 31.
4
Gene Editing for Enhanced Swine Production: Current Advances and Prospects.用于提高猪生产性能的基因编辑:当前进展与前景
Animals (Basel). 2025 Feb 3;15(3):422. doi: 10.3390/ani15030422.
5
Optimization of CRISPR/Cas9 Gene Editing System in Sheep () Oocytes via Microinjection.通过显微注射优化绵羊()卵母细胞中的CRISPR/Cas9基因编辑系统。
Int J Mol Sci. 2025 Jan 26;26(3):1065. doi: 10.3390/ijms26031065.
6
The generation and evaluation of TKO/hCD55/hTM/hEPCR gene-modified pigs for clinical organ xenotransplantation.用于临床器官异种移植的TKO/hCD55/hTM/hEPCR基因修饰猪的产生与评估。
Front Immunol. 2025 Jan 20;15:1488552. doi: 10.3389/fimmu.2024.1488552. eCollection 2024.
7
Development of a genetically tailored implantation hepatocellular carcinoma model in Oncopigs by somatic cell CRISPR editing.通过体细胞CRISPR编辑在基因定制的植入性肝癌Oncopig模型中的开发。
Dis Model Mech. 2025 Jan 1;18(1). doi: 10.1242/dmm.052079. Epub 2025 Jan 29.
8
Protocol for conditional mutagenesis in zebrafish germ cells using Tol2 transposon and a CRISPR-Cas9-based plasmid system.利用Tol2转座子和基于CRISPR-Cas9的质粒系统在斑马鱼生殖细胞中进行条件性诱变的方案。
STAR Protoc. 2025 Mar 21;6(1):103516. doi: 10.1016/j.xpro.2024.103516. Epub 2024 Dec 21.
9
Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German-speaking countries.1型酪氨酸血症患者的诊断、治疗、管理及监测:德语国家共识小组建议
J Inherit Metab Dis. 2025 Jan;48(1):e12824. doi: 10.1002/jimd.12824.
10
Efficient genome editing of two-cell mouse embryos via modified CRISPR/Cas electroporation.通过改良的CRISPR/Cas电穿孔对二细胞期小鼠胚胎进行高效基因组编辑。
Sci Rep. 2024 Dec 5;14(1):30347. doi: 10.1038/s41598-024-81198-0.